Strategies in Pain Management

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.

The Treatment of Chronic Cancer Pain in a Cancer Hospital in the Netherlands Rianne de Wit, MS, Frits van Dam, PhD, Ans Vielvoye-Kerkmeer, PhD, Carlien.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

A Randomized, Open, Parallel Group, Multicenter Trial to Investigate Analgesic Efficacy and Safety of a New Transdermal Fentanyl Patch Compared to Standard.

Managing Cancer Pain: Basic Principles and Invasive Treatments

Clinical Trial Results with OROS® Hydromorphone

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Use of strong opioids in advanced cancer pain: a randomized trial

Pharmacoeconomics of Coxib Therapy

The Public Health Strategy for Palliative Care

A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain Richard L. Rauck, MD, Mark S. Wallace,

A Randomized, Open, Parallel Group, Multicenter Trial to Investigate Analgesic Efficacy and Safety of a New Transdermal Fentanyl Patch Compared to Standard.

A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations Mary E. Lynch,

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety Meredith Noble, MS, Stephen J. Tregear,

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced.

David M. Simpson, MD, Lydia Estanislao, MD, Stephen J

Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial Elyse E. Lower, MD, Stewart Fleishman,

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,

Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients Laura L Adams, PhD, Robert.

Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer Alfredo H. Navigante, MD, PhD,

Barbara Strohbuecker, MScN, Herbert Mayer, Dr. rer. nat. , George C. M

Combination Analgesic Efficacy

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Coxibs—Beyond the GI Tract

Bruce H. Chamberlain, MD, Karen Cross, MD, Jaron L

A randomized, double-blind, crossover study of the use of transcutaneous spinal electroanalgesia in patients with pain from chronic critical limb ischemia

Gastrointestinal Effects of NSAIDs and Coxibs

Advances in Rheumatology

What Can We Learn About the Spiritual Needs of Palliative Care Patients From the Research Literature? Mark Cobb, MA, Christopher Dowrick, MD, FRCGP,

Transdermal Fentanyl for Chronic Pain in AIDS

Parent Perceptions of Child Vulnerability Are Associated With Functioning and Health Care Use in Children With Chronic Pain Mark Connelly, PhD, Kelly.

David Clark, PhD, Michael Wright, PhD

Redefining Appropriate Treatment Expectations

Clinical Response to an Outpatient Palliative Care Consultation in Patients With Advanced Cancer and Cancer Pain Sriram Yennurajalingam, MD, Jung Hun.

Long-Term Analgesic Effects of Transcranial Direct Current Stimulation of the Motor Cortex on Phantom Limb and Stump Pain: A Case Report Nadia Bolognini,

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Changes in Symptom Intensity Among Cancer Patients Receiving Outpatient Palliative Care Jung Hun Kang, MD, PhD, Jung Hye Kwon, MD, PhD, David Hui, MD,

Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study Kim Fisher, PhD, Carla Stiles,

Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction J.R. Sneyd, J.A. Langton, L.G. Allan,

Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

English Proficiency, Symptoms, and Quality of Life in Vietnamese- and Chinese- American Breast Cancer Survivors Jenny K. Yi, PhD, Michael D. Swartz, PhD,

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

Prolonged Treatment with Transdermal Fentanyl in Neuropathic Pain

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Improving Access to Opioid Analgesics for Palliative Care in India

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty Lowell W Reynolds,

Proglumide as a Morphine Adjunct in Cancer Pain Management

A Randomized, Open, Parallel Group, Multicenter Trial to Investigate Analgesic Efficacy and Safety of a New Transdermal Fentanyl Patch Compared to Standard.

U.S. Hospice Benefits Journal of Pain and Symptom Management

Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness—An Exploratory Study Diana H. Ferreira,

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

Efficacy of Analgesics in Chronic Pain

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

Paul K. Maciejewski, PhD, Holly G. Prigerson, PhD

James T. Lin, MD, Paul Mathew, MD

A Titrated Morphine Analgesic Regimen Comparing Substance Users and Non-Users with AIDS-Related Pain Ronald Kaplan, MD, Joseph Slywka, PhD, Susan Slagle,

Physical Function in Patients with Cancer

Managing Cancer Pain: Basic Principles and Invasive Treatments

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety Meredith Noble, MS, Stephen J. Tregear,

Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain Renato V. Samala, MD, Rafael.

Use of Pregabalin in the Management of Chronic Uremic Pruritus

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,

Presentation transcript:

Strategies in Pain Management Gary Ruoff, MD, Mark Lema, MD, PhD Journal of Pain and Symptom Management Volume 25, Issue 2, Pages 21-31 (February 2003) DOI: 10.1016/S0885-3924(02)00628-0

Fig. 1 Prevalence of dysmenorrhea among 533 women aged 18–45 years.9 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 2 Efficacy of NSAIDs in primary dysmenorrhea. Rate ratio for at least moderate pain relief—review of 31 studies. n = number of studies reviewed.11 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 3 Efficacy of rofecoxib and naproxen sodium in primary dysmenorrhea. Pain relief was rated on a 0–4 scale (0 = none, 4 = complete relief). Mean scores by treatment group are shown.12 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 4 Pain relief following third molar extraction: Mean pain relief over 24 hours. p<0.05 compared to placebo.20 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 5 Pain relief following third molar extraction. Mean pain relief over 24 hours. *p<0.05 vs. placebo and celecoxib at 12 and 24 hours.22 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 6 Efficacy of rofecoxib in chronic lower back pain. Screening (S) to baseline (R) represents washout of previous analgesic. Mean pain intensity as measured on 100 mm visual analogue scale.26 Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 7 The harmful effects of unrelieved pain. Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)

Fig. 8 The WHO Analgesic Ladder for Cancer Pain Management. The WHO analgesic ladder calls for the use of non-opioid analgesics such as NSAIDs or coxibs at all three levels of cancer pain. Journal of Pain and Symptom Management 2003 25, 21-31DOI: (10.1016/S0885-3924(02)00628-0)